Semi-solid state fermentation of bagasse for hydrogen …

August 4th, 2016 9:35 am

%PDF-1.3 % 236 0 obj << /Linearized 1 /O 239 /H [ 1988 410 ] /L 152378 /E 110030 /N 3 /T 147539 >> endobj xref 236 55 0000000016 00000 n 0000001451 00000 n 0000001806 00000 n 0000002398 00000 n 0000002869 00000 n 0000002908 00000 n 0000003067 00000 n 0000003225 00000 n 0000003872 00000 n 0000004096 00000 n 0000004311 00000 n 0000004736 00000 n 0000004958 00000 n 0000005340 00000 n 0000005558 00000 n 0000005792 00000 n 0000006252 00000 n 0000006282 00000 n 0000006323 00000 n 0000006551 00000 n 0000006573 00000 n 0000007404 00000 n 0000007426 00000 n 0000007648 00000 n 0000007986 00000 n 0000008857 00000 n 0000008879 00000 n 0000009723 00000 n 0000009745 00000 n 0000010624 00000 n 0000010646 00000 n 0000011550 00000 n 0000011572 00000 n 0000011728 00000 n 0000012020 00000 n 0000012831 00000 n 0000012853 00000 n 0000013721 00000 n 0000013743 00000 n 0000031758 00000 n 0000040546 00000 n 0000065801 00000 n 0000077006 00000 n 0000086677 00000 n 0000086756 00000 n 0000086963 00000 n 0000087037 00000 n 0000087106 00000 n 0000089784 00000 n 0000101530 00000 n 0000108385 00000 n 0000108602 00000 n 0000108809 00000 n 0000001988 00000 n 0000002376 00000 n trailer << /Size 291 /Info 233 0 R /Root 237 0 R /Prev 147528 /ID[<917cf852d21eec3aeb020f84b0692ea9>] >> startxref 0 %%EOF 237 0 obj << /Type /Catalog /Pages 235 0 R /Metadata 234 0 R /Outlines 16 0 R /OpenAction [ 239 0 R /XYZ null null null ] /PageMode /UseNone /PageLabels 232 0 R /StructTreeRoot 238 0 R /PieceInfo << /MarkedPDF << /LastModified (D:20060422135029)>> >> /LastModified (D:20060422135029) /MarkInfo << /Marked true /LetterspaceFlags 0 >> >> endobj 238 0 obj << /Type /StructTreeRoot /ClassMap 29 0 R /RoleMap 31 0 R /K [ 168 0 R 169 0 R 170 0 R 171 0 R 172 0 R 173 0 R ] /ParentTree 187 0 R /ParentTreeNextKey 5 >> endobj 289 0 obj << /S 151 /O 294 /L 310 /C 326 /Filter /FlateDecode /Length 290 0 R >> stream Hb```f``? 0Abl,{N400=h8Z|<< /Type /Page /Parent 235 0 R /Resources << /ColorSpace << /CS2 253 0 R /CS3 252 0 R >> /ExtGState << /GS2 279 0 R /GS3 280 0 R >> /Font << /TT6 251 0 R /TT7 250 0 R /TT8 243 0 R /TT9 248 0 R /TT10 246 0 R /TT11 259 0 R /C2_1 268 0 R >> /ProcSet [ /PDF /Text ] >> /Contents [ 256 0 R 260 0 R 262 0 R 264 0 R 266 0 R 270 0 R 272 0 R 288 0 R ] /MediaBox [ 0 0 612 792 ] /CropBox [ 0 0 612 792 ] /Rotate 0 /StructParents 0 /Annots 240 0 R >> endobj 240 0 obj [ 241 0 R 242 0 R ] endobj 241 0 obj << /Type /Annot /Subtype /Link /Rect [ 126.66039 75.46454 250.55365 89.11163 ] /Border [ 0 0 0 ] /H /I /A 281 0 R /StructParent 1 >> endobj 242 0 obj << /Type /Annot /Subtype /Link /Rect [ 262.74039 75.46451 361.06534 89.1116 ] /Border [ 0 0 0 ] /H /I /A 282 0 R /StructParent 2 >> endobj 243 0 obj << /Type /Font /Subtype /TrueType /FirstChar 32 /LastChar 181 /Widths [ 278 0 0 0 0 889 667 0 333 333 389 0 278 333 278 278 556 556 556 556 556 556 556 556 556 556 278 278 0 0 0 0 1015 667 667 722 722 667 611 778 722 278 500 667 556 833 722 778 667 0 722 667 611 722 667 944 667 667 611 278 0 278 0 0 0 556 556 500 556 556 278 556 556 222 222 500 222 833 556 556 556 556 333 500 278 556 500 722 500 500 500 0 0 0 584 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 556 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 737 0 0 0 0 0 0 576 ] /Encoding /WinAnsiEncoding /BaseFont /PPAPMP+Arial /FontDescriptor 244 0 R >> endobj 244 0 obj << /Type /FontDescriptor /Ascent 905 /CapHeight 718 /Descent -211 /Flags 32 /FontBBox [ -665 -325 2028 1037 ] /FontName /PPAPMP+Arial /ItalicAngle 0 /StemV 94 /XHeight 515 /FontFile2 276 0 R >> endobj 245 0 obj << /Type /FontDescriptor /Ascent 891 /CapHeight 0 /Descent -216 /Flags 34 /FontBBox [ -568 -307 2028 1007 ] /FontName /PPAPAO+TimesNewRoman /ItalicAngle 0 /StemV 0 /FontFile2 275 0 R >> endobj 246 0 obj << /Type /Font /Subtype /TrueType /FirstChar 32 /LastChar 122 /Widths [ 278 0 0 0 0 0 0 0 0 0 0 0 0 0 278 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 667 0 0 0 667 0 0 0 0 0 0 0 833 0 0 0 0 722 0 611 0 0 0 0 0 0 0 0 0 0 0 0 556 556 500 556 556 278 556 556 222 0 0 222 833 556 556 556 0 333 500 278 556 500 0 0 0 500 ] /Encoding /WinAnsiEncoding /BaseFont /PPBACJ+Arial,Italic /FontDescriptor 249 0 R >> endobj 247 0 obj << /Type /FontDescriptor /Ascent 891 /CapHeight 0 /Descent -216 /Flags 34 /FontBBox [ -558 -307 2034 1026 ] /FontName /PPBAAD+TimesNewRoman,Bold /ItalicAngle 0 /StemV 133 /FontFile2 277 0 R >> endobj 248 0 obj << /Type /Font /Subtype /TrueType /FirstChar 32 /LastChar 116 /Widths [ 250 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 333 0 0 0 0 0 0 722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 556 444 0 0 0 0 0 0 0 0 0 0 0 0 0 0 444 389 333 ] /Encoding /WinAnsiEncoding /BaseFont /PPBAAD+TimesNewRoman,Bold /FontDescriptor 247 0 R >> endobj 249 0 obj << /Type /FontDescriptor /Ascent 905 /CapHeight 718 /Descent -211 /Flags 96 /FontBBox [ -517 -325 1082 1025 ] /FontName /PPBACJ+Arial,Italic /ItalicAngle -15 /StemV 0 /FontFile2 284 0 R >> endobj 250 0 obj << /Type /Font /Subtype /TrueType /FirstChar 32 /LastChar 51 /Widths [ 250 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 500 500 500 ] /Encoding /WinAnsiEncoding /BaseFont /PPAPAO+TimesNewRoman /FontDescriptor 245 0 R >> endobj 251 0 obj << /Type /Font /Subtype /TrueType /FirstChar 32 /LastChar 121 /Widths [ 278 0 0 0 0 0 0 0 333 333 0 0 278 333 278 0 556 556 556 556 556 556 556 0 556 0 333 333 0 0 0 0 0 722 0 0 0 0 0 0 722 278 0 722 611 833 0 0 667 0 722 667 0 0 0 0 0 0 0 0 0 0 0 0 0 556 611 556 611 556 333 611 611 278 0 0 278 889 611 611 611 0 389 556 333 611 556 0 556 556 ] /Encoding /WinAnsiEncoding /BaseFont /PPAPHE+Arial,Bold /FontDescriptor 254 0 R >> endobj 252 0 obj /DeviceGray endobj 253 0 obj [ /ICCBased 283 0 R ] endobj 254 0 obj << /Type /FontDescriptor /Ascent 905 /CapHeight 0 /Descent -211 /Flags 32 /FontBBox [ -628 -376 2034 1048 ] /FontName /PPAPHE+Arial,Bold /ItalicAngle 0 /StemV 144 /XHeight 515 /FontFile2 274 0 R >> endobj 255 0 obj 751 endobj 256 0 obj << /Filter /FlateDecode /Length 255 0 R >> stream HU]O0}Tq! MHf{7IfJR~SMn-Oob~H%]a5$AShV}[`%<9*cB^A0GH2e.u_jahVp?3L_)S,w5-l^(Wr5N.f]xlrW8o*(?s{rr '!9e*i-.6P6eE5}|'W7c?boY.UOm$%sUxd}D)E 8W*5,-em1z%Lc9bs 5N0p:.24 2T2;7jIYL C1M F|D CcrRCC$Y*Ar,:eHQyJ0RIiST%,]yqyiX M# ;w{m4vY][_7> endobj 259 0 obj << /Type /Font /Subtype /TrueType /FirstChar 58 /LastChar 121 /Widths [ 333 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 722 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 611 556 0 0 0 0 0 0 0 0 0 611 0 0 389 556 0 0 0 778 0 556 ] /Encoding /WinAnsiEncoding /BaseFont /PPBAKC+Arial,BoldItalic /FontDescriptor 258 0 R >> endobj 260 0 obj << /Filter /FlateDecode /Length 257 0 R >> stream HUn0+R j 8CUo6c3Tc_d4Lg38/&_1I.Y04PZ _y(KpP>NrxAR?n.]"(dN jNJ&<]6SpUNtNT!FH6xN+Md^h}*LcFsE *~lS-r6s>8a2u=xcjBN"=0I@H:fTv^vN}4mm/ NLJ*4f_55v=B.$U~Q9[jUyokhz5u?IQ1 G&YvU|$<,D RiYYN "KWal'18*J"cE$R OX9OZ]sL96% fpD&dI~0!r27oJ+:hr7&?q///g_nofr,xbE21Y]xyh`IHMKfm}r Eh1I:) 0IQ>|Zkg}@o, py+ED"K!HoJ endstream endobj 261 0 obj 764 endobj 262 0 obj << /Filter /FlateDecode /Length 261 0 R >> stream HUn0}WUwY@Q`-{SVu_?E^:!QJ|wk&/I_Bq}XJE C%hA8P+1m 5TM>>nM}wz(c?,-l8q9aHfwMh`8dweT7m.m^(B55L}V:"J1z=^-fW.f'?6o7$_^ftd7Dc!5'cb6_c,PQ/oISrQ$DlC~J{mr1S[., PU%dpm:;=Q= 'MW"~52e pL_!]*T?[6=65f|SBIw_|De5tH 9IcY>}!-@>gKs]JavYc0UKqGn~7TJh)(IZjpyC|>dnjjzpmsHb)^63QBlrh: `x4U1!~{&12n58qHOEjs}+ endstream endobj 263 0 obj 799 endobj 264 0 obj << /Filter /FlateDecode /Length 263 0 R >> stream H|Tn0+R , FmhToPV{x8Ynf{i~wu{ r1/90X,g%% YJX?of'pxE;aQT(z/}3Y0y84+J0t4uKm7=-UAs MeNw[$dzE(=$$y8L(:r~'x)'D&x7f[1K!`chZO#,v3igvjcCzmsV`2'_ka~p3nq{?iZ9(0;=f^TZb9)8Kw.&o %c|@ItB+@1nVP Rigb (:0ar+3y)YJC59/hF)#2,Vi`/)%f .S7g}k^wl.CS]xsA<< /Filter /FlateDecode /Length 265 0 R >> stream H|Ur:+z3UIUF$'-Y`F3B,M:2eM6GBcB+`RNsqM @{7>r 5;;xx&L)MDlKh1/GSx7[8NQASDTr ]Fp>Ven5~YG3<]N//X!Q##}}NGcz%6%o[3M /GSTLMy4/f/;15[snZW/GPM EJ7m]%]u yZ3LRK/I-.6{_b)C wc1T22WBvtqT9%$J5@7GT)-9ZB;XA2X LCkzT%hPB5wu%NIue%`?T;f]RTOG-S\^I'B:V<)As XZ{YUfm gWI2^;S!4BZmFtv?V7L6c!h]t:>N=:nu /P%s{I8x~J2bA%0&+~<} ZVXF`:L}L}~8).?nU.gY^wy d endstream endobj 267 0 obj 731 endobj 268 0 obj << /Type /Font /Subtype /Type0 /BaseFont /PPBBFM+SymbolMT /Encoding /Identity-H /DescendantFonts [ 286 0 R ] /ToUnicode 269 0 R >> endobj 269 0 obj << /Filter /FlateDecode /Length 217 >> stream HTPn0[t6nwE1%: :n 8m5 R;U ?N9k]-g^nzj$[pZq`{Wj endstream endobj 270 0 obj << /Filter /FlateDecode /Length 267 0 R >> stream HUMO0WX$j8 q *UD9jIh8`yL,_t}}^CLUtEWY&E.",GpLQ82Do8IR1b*Jt]d gWgjQGoj*jL r`n>A[] ) jsm|U>Ntc}0$vh(c"z4607h(g$dXpP{,M0JL_Jc%A J`I!]V8 q0Ix9C3xVV4k& fvi{}RN *C%s:k jX{`^1XIy|Xwa,oM ]U(s=FXhC%X`1gEC(`"1,*!F;bt6h%Non 10-+8x~k[[;H+$gdxw/D<< /Filter /FlateDecode /Length 271 0 R >> stream HU]o0}/R)ql>V[M+&HPUl"s&SJD1Mo[Fh1HO( H3]_^@gp|H)l5a@V9|I=l`S+[`SAXXMVa{fe ~ Vq41]`? endstream endobj 273 0 obj 770 endobj 274 0 obj << /Filter /FlateDecode /Length 17923 /Length1 32020 >> stream H|UtW97oA7 MZA$7!"VDR"&3N)5J=:z.YYJJ(r2Ykz:}Hd8TA`^fNuw>3 ]'5iRsS!/mse'M8}H%|Y8w-Z1x lz?wNu*A5isO3*7QtveDy:DX0y?]jy~e}o[ c+A(nS8% X_7:+:db8 sy :mTen1n3YqI^@gNb<6k AK1wujvoXd1RtAjEylbLq)X7)~xn e5eb47s#3R4BU C|zficmGhm|'=z&bSDYae(tee[):V[duYwu/uov7f |c,K9O4&;ZF5e#'k.^`?Ubk?sqJR1|^.?`z5RQ&G&Qj~%Rd)|gVnv wpoLXzF!g78 dw?4qTLUTC}mV'ZWE#SqBp8$Mby(r7(dKbzq8I~3k~#Iw$QRXrZM4eo^NnY>dpSfw`R B~7$pgITHE; h$zsHIIg#.gTCjsfo Ow4vw^<,y39!Pg$yv))7eUu}Jw3Iq`P^X I-aMGNyZE(:W+l]m3jh4l~/>}P?ejaEVGdWZ7DP@b)K={8:H N8LIaXSqOOO 3W{}0pK23 xB~D$2 3RrbDW$BAOro7ntA)s[y K}9 yEbVH .Ud;$'(")A5 QVLp:!U)dk s=`faaP0^5Y+*b r}2M,VT82_iHn.$2ml/zs~[u;ImA! ZAqi+-A^5V~*F5ngQ< d,YP8@p;*KvSM6Dw!}AM K[OCxVbF#H#/#=o1&C8m`aG$:7,dx#`#`GT;Qn?7yc9abL} :[Qcs8w9 e1?a< q>hT2~~9^[JkPhKX`Y*(AFAa~;nz`/A1(# 6Y B5=/cD}?-J,mB{<5eka*1~-Ck,G-kGP:X& :|$4G]Iwa5w.pO=q7,qjONS4t[[|w)G>s>FoqwS' m.%d^=mv.23f;=)rs^tQ-VY(=Z"bUQ%-v;mTh>JyJWR>j-H([DcU'!]xg-Uq_Sv~Tz y4V6z6Qz)5D/4,=wf=.b.4&@A7)#Lc?Gx_qdyzI)""kYiX'r"C}{}Rr6oBK8%ge+{{zm?s_^>'{#3|. %|Vp2G`V6w@7&cr,9V%Y^?^;3@Pka/|`v #>gs3f0Z~;kqcoN qYX7U|'oq,3^;J+$oCCCEz6upsLKN8nAPT5H&KMmHiJ[ik|npU6uX4*a)NKDwiyl~0bk"U4O@"+%w[Ub@3F (zmB2KvEqDtQ)y}}Pm{ g=i@~*BK%(F>civ ! ]]eV.>9NEae}(BBoDobnKW`(BONg wHtq b L1P}4CMjoc$`{?(.O$ 0qPs3,,F(L7_a-|(6~/f;n|kBKF0{5,?.I*I4nitME@ge5!~XK4GV Xc'@Ye_ }X?=.Gtu6Wr.Q7 m+CL(2F]E4!FBs C<1Q#ni=$rAGTHh** _MA4#S47TG#*BNu(hF?WciQ72t"$r_3 85)[NyEq{?I85)pf7p{wvrho#=lXK6}&v7q;|'IY-$Y D%* #I|% I>5X -D"zS}oEC}op&J^GY=i7pnG6tD7Sq7D"6l`igmzjiLESKs UN)|,zlg? FYk6[Fo$IKuR+<,"W,u}}YU7q-rhUvbAox)Yok8{#:i'u'JqY*%TT%+UXY<{p72Er,= @`Pp"7uILJGPWD1X ,{{6=]{3=_O@- ]Z'eb>D |/{gQhrQ$RP@ ^G(K^'X/_JD2NN4LJ'vHHRu$iE>5ImnSUIrVz59*.N44pB EyqQ4 3Pkz-4#wpsq|5Fs:dEANHR%HU: PBD T>w'IzFx_pV.OKB/Hd,ULfT'*$J%"(+3t(d%Xh1-k+{uw[3f^r4Pv=^o?g7V/m[vm95CO3)(!ZNx_8] #48D'gitT7).o,E=+(/CLU+e1,v;8cX=r5lS^EUFxQ^[bVbtoVSQ9 J YGcyZb4_j,7hw5*`8tM0Z!p7#,%jtpaJOYf)!`"ADQp!sf< Lx|/@8!@7jM%kvVU{:N;l6O;<8!QEE>O)?e#jUnwht% mZqIE1Hn&2.JMVnrrwD5p371XySMUqa2b 9T:qa8b)6d7q+ >E7lH=mzo[sqKJJ[wkGx_osUm@AUat v(_o=j+pJ x[~q7c`-^m |RrJ(TRCHgt-G5(R B];x1dn(j@gBt%+8Ju gX3jyr,jKYL dz0(8SN7g|oI)@UdS63hn-`<:c+gxme4w7ws;Qi!`2MZfi1x% etPo+h?%cBJ?)`^%dj,eEl'}<&'mb<'.+]Wur}.!y2^61VD,md5'il&ge'N ]pMK, @'X_E2CS'u.F-t#`.Ywd&+N6NhNQEzHt`"`Pq+I 7JA1._S#f`1xUt~l!`)aQ8X'g'Azurl8g|nj77H~_vARV2l"5-; y7k8 jij .Qts~dMEvh%%!((GR^V=O;`g~6i{y_^]=sWvK%,_iegY%a[ $"Q H1K t[p)M`m FHXW`)q~r($g,=> K(DoH u1~>_w1fNS5)<2/XWs |xqorm~uiOv{7x;XXU8/+h_&e0B8y@J5aK; y ?P2`'bm6-=ASTG^&y3W%oB/q#~Lc"WM(p~ k RJ)&5.c?V{d_QHU89hE(9%Q4sVvok$##{e)Gsk]T27lWO#rT 248C/P }(~qUh5-oY "%m$)"3>plK#a7 2Qs'7u aCtdP,naZ|-jkI vG$ki;/d#COQyf.d@*yo{xxjF0.RFhZ}[NxQ}_o9oyo)i^iuL*}m}mvkG#!i- OIs1*x0uIx a~rjF8XU=b G VHa`4&?X "j;!Cq;bNg8{ob X__`UIq^@Q-fUon!owmEa$#m65} v-o:snfYSQ1IST:C{BIh{MF04]5Mg|};qw'$2B}qJ,^W )Sti(Td 4@VfTvCS' uc B"IY;hJF1-a1Xq!]#(uDS& ibHQ8Rpt!rMe1OaMV=a]/ZhHiX_+5PYSTyzvg"}BG5U@3U(ed][/wI4^RQ^U'a6^fh]2!2dciYh~NE6&nca>,fS^r8F@@GN_,f8ycTMn7A+1Wf6Jd -+3= 45 R%6K@ RTmA%@Swlzrukou'OjG'~xlzP,q)Z*} e:K-v%tc0WDXeYUDrhC8/"{;KUcRAc){A[ OL7[SPCCr!0Kcw}uExNh?5yWLo0$9$ 9BpdM=;Aw.M2,AS$T*B6ahh".IP>]H)HaQ^ n/w "sD&|RD43G/W4n"bf'zb'K|k7A0Z4BM-`O|LXD8[{a3E"?X=< v-ta"!)_dy+4YbEI U tS7$ /P B-DpBTU5C)',o ^%pJ5thC# D4JvFO7b,:T:f(L7ST za^Mxj|<691;bd0L&N^6XZ,0 Zbv|.kf*fh j Y1kvVKSITcn4P[~p;waYKw] 8X*JWD{{2IcqQZ'7z{p/k(=3-WN)()a`|s3@kz)d9jr%`qCcQp}wP"/^;Juws0wS'{I".L5B+Q&W +]qA>LD}bvCES`{V-RD/fQ^} "i1in27sf;'>OF7;hbowRVxO8;IXK Nv{rH~;P?4>)5 vtMg rr lwOS/4z|y]yE?"Z8{#.)dBr J 3'(>mIXx;(0thJBMv";FF)i0^1Q3cp#iP#>xV=wzs`/l{0btW1{]T`d: 0EQ'8vhiMy 'e7oZU_~3weis7V!r?q]y{4A.1jogB+ySLe"|^H>fqL3I|{Nm8w2_5p*%-SxN L!N$FDFdF3b:Nk:48/Vj%4j?xHJA3 @v TqDDYIXJnTnSPyuKZ$HG,HOB/!0`,flk?s>d7Md5]=fWARF& :?&9TolV4DX7(7%#mi^d)LbLlvCFIj%i= IQ^M?FuQw}Az:MgS ;:?zvbQS,}SN }d|0>gOPULEs5:f-{Q]X+D Xh-p-^%H7&bJ~1,G?fStsmOZr; =9Mp>VI;;Y w-}!$` 'OoWU$ R;fCk[8nrcch#y,W#3 HsdT >mP *vb?()l/PB %PB %PB %PB %Pl3",9".|C_T)=]?w#0|m#pg04y4A+*Xa3H>oA$qGwtC/&`>nOw;d]x>YDY*Rf)8a(~Q(((3_3gZz1*DtAITSLw8N| @V@ !AC{8Lmpn~{|8BxDfyK!;o?K) endstream endobj 275 0 obj << /Filter /FlateDecode /Length 8697 /Length1 19988 >> stream HUtW9o$I1r+g(F$AE(-K>|.@#{9 @]N7I=]|wp,tVm3Io*e_Et.D6 zM8nUTR:vphy2w 1ed+0knw'<'o@4VCIT~Wz)G`4lED@!abc.ULMC,2qE;]gbC`b;JA"/qT#Vn!Zc6G#W&VGDb3g%VfB1Wm06Wm"2jNB^xW(%IY zI'V$ D+a$&a:op=[7fk>C2NTeCq12@K,R%rH5Y~}D_:I%1EYw+J$0s-3{AZf1>4|*]C/S[2O^ [w:W/+kkd6701pdwYZ#Sn@~>b fa.ce6aqoH$9cv|YFer]~"bUgKtU+ uN-h=[!6 g3tm>@YfIH@;2]HGGq#Qbn>A0b$/El#Y*Q{9XG:]g,e[VkUh['S;EFccccv;g98MP4O{~$:T5C]>{cj.)@jz`tDOsv.*C]O$5AV5HVoI:yH7U{: uM5Uj }2Xh`{EV6vj~V+&%ddR3F UWHwJ^ct(1*TC5LsDhiD55C59-5}5m_gu<=^SGqt^"Wk11,BGP-m6*Z8QPg!.jZ5oX*S8Z]i0Fve;[o7xvQ's@R8" osOl+gxGxryf* 1lN7;5:RcAG2v.Q%d^f9P#-z%xej*MADH0L1w6gZ)))z{r]:wRmhIF W:ANmi%hs~+MF# 5e}}#sNdw.54E/=X>W0yt&_ }zT0-Ciu?-+8LPTp4c't([YYc*czohbHeXN%V^S[ FHWQ1QZ To{jfx.-xA`/QoG8GIqkXrOfMhx}0b0FEqYFTGo,>8&b"f$~nc+r~#'0>|PFV+]rIuoR]0;(OS&g@e@X<4 |p vPk:E>W+QT[CfTrt%{z+Z1n @?<*F=`! ucCFak"/Fy.1_V(I=`8A8` xx`? vGcfn1g }{ 9&uW[ s+M0YC:@UY6D89&)cRt(#_> B.=M$2hfR=T}-CbxUo,NkRErZ6r2`X2uiGoA%<W~G0zC.oYB>_fi4_#.%B9'XB%1sZ9zCN(ssIJw1UmAUG-s2?sx:ii?`/ir$dnvcrU;_=h/50B={9s~jvgW#/S4#y;:M<,T;nQ2mcX7{M.>jErAy9v (OS)c{Aw`/yncfZ7yTpAUX?(o5Z]GS4M(KoE*AG~G2WKi~Y Z*s$w Meh:t *o`(iY}{MOx-Mcl7ln,=9>1(wa2B~? /& mwUZCzH=nu;PG_?hC>89|!|3(}/oP~3[q1~[07ix@mc@*?nuXkJGl6>G(rQA>= mPE`O?z)FX0UP.>Cm/Kut hx-a(22k Uispo6zjI3ufhos7(gi^5xLp9*ll[Q;Tk:?!9;=ywGM^|2y$t'ok?F-m"{1=P'|9f;#U?o !cPR#m4V_;Kvh{Ml|)~'ao]r1/ wSh3|=]p.Ed1:`fB1jZmv]5KIt3tQv9g?d<9={}] @Q7 a=zlx.7=n~P #JNa9n dM@!Spy{w9]K[D_7IN"sADa(O`#m'F(j A ld+{g]c_dBK}}iJ_FdZO=P'(Z:;&`vJ tOJV.K}XN,}'V+IlputbVt 1XR^aa-p'zYcfulgb_`Oa TbInn9OlDhfZ"Uz[XRD=d-B(`c-Va =F8.eFi%$rVxCUE,}Ep$hzmmzok|5~[XpD/Km>KmjV.a, #80sm@2":Lj8QiJh rkj"^!C2:v<)5>iQ'n va q vr @v0+)C,`hrh4YG,#*f*U 4?qLrhg#ZMD+h 'P*UcFvQa~J7_{$_[dKv %WI^nskN%IL?8DZ"T:c"Vh3::/|V YHN+maZd: !n?SF "UR+Ji%=GVUO[)UOXG ?!OLpZ#NRSLS+tHuR+qKKtbsOj&uk@GgpmCe$/_&68. =G&bzva]zuxSVz {pxBs;a@iG)a&dX6-"m3%VB>2ZCLu_j:'hC* 8SY~Z?E0M4]RW4@Wk-Omj5Qs6n&=:JZ*QhjSkcD@lwLDY+>&/87wPHf[Q;j& mwjd))M&i MT+i"RVDjI?dTh:Jqi7ofvv73t5Ck}r}/?)[6ol-Bp.^]Z5:MhvF>4/t 0Lg&V]H -?f%Y1N2 NM;zooap#(b/B_ =b/D]9f]ic#lHC}SrolZ^Fy%j;N 7?"F!p}UJ)jTRU-p6U{ 4+0 (QdLj$DC_V)IXz *i]UsMUdu !V}U]/&a?KtyPdd]:n2S.Qop:NjD,yj8'S'TY&TSH}[4Wq3q5*uH;ux}};:|2""/?;?L:+MR}UOxKvN[G_j=6[-#qDn9%[srrO5o2WgsUUdpyN,~=O~+O{_hZ~Yh1Nh*WX9}h4?Y~p3w0`0`|0*ia$RG&}:}PCd :zIA7V"[RZA :LA7ZOO'9r@C{F?qmx0G$CFvAcic E;e)1$[0 bmf%O?=v[.sK, endstream endobj 276 0 obj << /Filter /FlateDecode /Length 25163 /Length1 40172 >> stream HT XT FFDbkAS%VMpAOiPbjc5V[AIMS$,D31Z;{ss@$C"w)>wP_rdAn#@ix3o|{nV%Bls3~_ '6*w*{[(>lx"R1}.tM=Y~XIi0/^:j3tM3,2i2WYRXn)*q?`;Wv8tWHbA9~K 8B_`!z1bX(6ztF|+-cd/p/+8VdSZA[lO;o'@`u6p d^FW>C;9{/L>Z7!;;%R*e12i&U"FJBc'ts=B9?.QbXTbhUFL4Y,VwyE~/b2pKIPhe2_USSpKeOTk5:zQma%BA8qZ~"-SEKIVYav%~W"d6 )fhSqm"8)|*/U)Cmb.8n8d=JZVZzDJ )rsh{"1p$ZEQBI]M[-yGw}/vu< XU4W`VR $=xO*8Tiv90Rf$;'bOL/PO)vM%jSb:MHyPcV| hs9(Kj, j<_F;b5~d"U'ZC~/8y9>"fO G9p*Vgi#R>|! >L ^#nC;EwEwZTE BKhFP1ck}(AC5XsiLIpONfdZ3Ms3.C7H6Aed.(<1"<]O/ONBcx1bR)FHN.#Nf`xs2;IQFGgH0%hejFkL:_Vy F_o;k.2-k47ywo~>`[gr Gn9$XuWPQz70~vKOtcDw=>.M{p'91`:el3BH=Y f? ahgO`?VFH! 5>Z7}{Wb { HL5sL &'-h!;^^w}WuUu %!@!$$ W D!uK%<`&<%@iAbR*6RCC;S(9~k}.7/^k^{YtcJz5B 5efl 700q63JDot:U&*1tUYkBIHAGTJM(/rZ+Knh1`0.%Hw:3<+J8iI 6 5LRRqtEDrSs#e-vxEjrBj~N?0 hnU)|ZI=}k!Jkr.}-{Z!N_) ETHO0GQm<|}!W`*PQre=}1GF zm0pz65XShCwFM6j~%t%P^~Wo0`A?Rib&R11 m3ZUjmv=Twx.7rC`4E"um[W6 x`_+6/*>BDsYv'^kxnA~w)#88?7"9J!u+o<.m+>b5 Bi7K]=jf:|!XE^1l^#J{k?aw(Q1=}"nN4|US7b:R;uf1[% k[i?F}v/~6vA:"_V1mx:'H?I_xp|/0=IT3TSU3q "= W%rS%r&g:`&rcw1^k0'PD9V9UCWm"Ob]mT&z;2FR6;R1*3{mBCw H]Z@OJ}67w!n=%#4Xt;OhWhh*E"25dEzkk($%}S,qx{~'#CM!gk;G.f.Ac^.wtm}r<.q4jjj?,c}Wk@9@Zp@4Wq w `@/[Ppv@o0YI.`3i"3t7n]t_wqf!R@K4.2MK]jWk#Vi^WkO~X<1?O[K{VY!'m"cZ;G!O#&_Yz3=O@:9e?x e3b>y6.]s1 wd;'R O3"-n@_C D?BQHZ/T_DQ97kPx?k= >XqE%(? -u2,+a0io;fw?{`=%nefzhg}TxR?cA?X,~< -+oV@-jm7 I'1 !$Z[RXT1]Di+uA#]N@J-i71WcGQU06kF=v0egR"B>&Uj&(B@95,dmw65Cgg=`g(-sov0f3) v!`,:]UU_]aW0O 5cL;rY)p&XN(~d]":0%t~(@;l.L4pMI0 v1k{)}hy~veF [|H]NsGW lvtrL'8o7EnU_x!eTcrz''v '_x|m@ vr}T ZVi4U &6os;// 6N3T[C7KTC&jTSvRhT=DAuRmjR-F5VJ5 0a}+z='QS!RJRB7%#Tbel p h h L+8l&Y .lW`C`0y1=U'kl }Muh |2"[5["|_-.%I?+ BQ_P9KPqI+w $nnFVHcVyK^B&YQ9 Re)Sn9&X2U[%NKeb'E8_'fhM"HTB%yf7}?!ocAsD6)zK6S!f}?$niN0G J::4CsPEFprz p>G#k;z wJw#wv 5<. E]gB@snpQDwJ7=t@I]Yf3QC@!1C+P[3]MYqhdL;4WI-ZD$C""C2-HI5RJssNs{6t1; x@[IQ7GyB_[G!}77v?%0wtwxnEGZkY;Zt=OX|V{sX$aY=.OaniGyf=A=SS8E:eC8L}~7p m%H@,L8I&=F+o/<2"L>P3b$Cl|BRK-j#ElXr0,tE~61{<6fEu9exF 3lq.lpW]f*XowY??.flM8^d;[]l.veRTt^e)fI)_Y-YX!*/h>'SGmID.s-q%>Zbs,_Vh-_8qoe0mhv5_OHpk&/ +f:q'>g qd,QbW+*hllrWX1/bv`2}@aJ#?lWp{I;,#qDCD I0B'5YxE.yt ]()Yi4,l$:Y5B]NO/i>aiZ<2mJI&~ "-6_b*Dq/Ch5G)GGIJ Adyg/}2|z[d[;GH9ydl$)E0;S lt; (a6*WAsR3H:tw+$J`CO"o$V< nnSp? FaEV:."wo08}`Hp&Wh.1@ZuHi|Y2i4itWX,s" BGW)3bt_5F*]^'k:E3&(&UTO [ZRusA "kW7!f0@1*W0WQ2(d1xeKMb}M3|U7 dx3h4z9|8x.A#GE}F*8ef@a#3>l!MCxJ-Q( *3Da_GOuZoYK9@_A|.tG}ye.ednP,,VZ[>--pAsHRY *hK*Hd;pNeOD!Gc}[EAu|uzF}w)%6B2} U*BxLxX?n*UBh<('Sy9QbyG&sy_=|?Z*Vh_u.hmH<-,Ag7;WrjkbAmzqL7Qh49$z#t FdvR7qoq x1J^mFpi?bcEY`s E W9?@y?=)wum'?k2h# R2Pvk7d;w/|zuL{ kX&>:+3+~@SXcx !A6QM"RoyD t=0L 'nowwy`

Here is the original post:
Semi-solid state fermentation of bagasse for hydrogen ...

What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Yahoo Finance - November 16th, 2024
Department of Biotechnology Launches Webinar Series on Biomanufacturing and Biofoundry Initiative - IBG NEWS - November 16th, 2024
Multimodal scanning of genetic variants with base and prime editing - Nature.com - November 16th, 2024
NEW INITIATIVE BY THE ITALIAN EMBASSY IN WASHINGTON ON BIOTECHNOLOGY WITH THE MILKEN INSTITUTE AND LEADING RESEARCHERS AND INDUSTRY EXPERTS -... - November 16th, 2024
Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at... - November 16th, 2024
Albany State offers new Master of Science in Integrated Biotechnology program - The Albany Herald - November 16th, 2024
What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Benzinga - November 16th, 2024
iNtRON Biotechnology (KOSDAQ:048530) Is In A Strong Position To Grow Its Business - Simply Wall St - November 16th, 2024
PDS Biotechnology Highlights Clinical Progress and Q3 Results - TipRanks - November 16th, 2024
We Think Puma Biotechnology's (NASDAQ:PBYI) Robust Earnings Are Conservative - Yahoo Finance - November 16th, 2024
Puma Biotechnology's (NASDAQ:PBYI) Performance Is Even Better Than Its Earnings Suggest - Simply Wall St - November 16th, 2024
APHIS Announces Final Notice on Additional Exemptions for the Movement of Organisms Modified or Produced Through Genetic Engineering - USDA APHIS - November 16th, 2024
Adaptimmune nears second approval for TCR-T therapy - European Biotechnology News - November 16th, 2024
Lundbeck reports 18% revenue growth in third quarter - The Pharma Letter - November 16th, 2024
BioNTech to boost oncology offering with buy of Biotheus - The Pharma Letter - November 16th, 2024
Puma Biotechnology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance - November 16th, 2024
WPI Receives Federal Funding to Address Anticipated Demand for Biology and Biotechnology Professionals and Educators - WPI News - November 3rd, 2024
Jonathan Dinman to Direct the Institute for Bioscience and Biotechnology Research - College of Computer, Mathematical, and Natural Sciences - November 3rd, 2024
PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of "Buy" by Analysts - MarketBeat - November 3rd, 2024
COP16, DSI mechanism for benefit sharing from the use of digital sequence information approved - Renewable Matter - November 3rd, 2024
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets - PR Newswire - November 3rd, 2024
Axonis Therapeutics raises $115 million in Series A financing - The Pharma Letter - November 3rd, 2024
Regeneron third-quarter 2024 earnings top expectations - The Pharma Letter - November 3rd, 2024
AbbVie inks up to $1.4 billion deal with EvolveImmune - The Pharma Letter - November 3rd, 2024
CEO and Chairman of the Executive Board - European Biotechnology News - November 3rd, 2024
The transformative potential of biotechnology and AI in healthcare - The Armchair Trader - November 3rd, 2024
U.S. Biotechnology And Pharmaceutical Services Outsourcing Market Size to Reach USD 16.68 Billion By 2033 - BioSpace - October 6th, 2024
Vir Biotechnology, Inc. (NASDAQ:VIR) is largely controlled by institutional shareholders who own 53% of the company - Yahoo Finance - October 6th, 2024
Resolution Therapeutics scores 63.5 million in series B round - The Pharma Letter - October 6th, 2024
Wiregrass Institute for Biotechnology welcomes local military veteran from Southeast Health as its first computational biologist - AOL - October 6th, 2024
Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research -... - October 6th, 2024
Sapience Therapeutics Announces Participation at the 4th Annual Needham Private Biotech Company Virtual 1x1 Forum - PR Newswire - October 6th, 2024
Spyre Therapeutics lures Abivax exec to be its CMO - The Pharma Letter - October 6th, 2024
Convergence is AIxBio: AI and the Bioeconomy - OODA Loop - October 6th, 2024
Congress targets Chinese influence in health tech. It could come with tradeoffs - ABC News - September 13th, 2024
Researchers, media engage to educate farmers on biotechnology - University World News - September 13th, 2024
Congress targets Chinese influence in health tech. It could come with tradeoffs - The Associated Press - September 13th, 2024
Comer Delivers Remarks in Support of Bipartisan BIOSECURE Act - House Committee on Oversight and Reform | - September 13th, 2024
Announcement of $2 Million for the University of Delaware to Advance Biotechnology - WGMD Radio - September 13th, 2024
Thailand's Competitiveness Enhanced Through Advanced Biotechnology at Thailand LAB INTERNATIONAL 2024 - BSA bureau - September 13th, 2024
Biotechnology company Amgen expands global reach with technology innovation center in Hyderabad, India - BioProcess Insider - September 13th, 2024
Adam's Biotech Scorecard: Can iTeos and GSK solve TIGIT's troubles? - STAT - September 13th, 2024
Cizzle Biotechnology Advancing Lung Cancer Detection from R&D to Application with Moffitt Cancer Centre (VIDEO) - DirectorsTalk Interviews - September 13th, 2024
MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer - Business Wire - September 13th, 2024
MAIA Biotechnology Advances with Clinical Trials and Partnerships - TipRanks - September 13th, 2024
Viridian Therapeutics reports positive results for veligrotug - The Pharma Letter - September 13th, 2024
Chinese biotech firms refute US bill, stressing they have no access to Americans personal data - Global Times - September 13th, 2024
Vir Biotechnology Enhances Portfolio with Sanofi Deal and Executive Appointments - TipRanks - September 13th, 2024
Tesla BioHealing and Cell Biotechnology Partner to Advance Stem Cell Therapies - Vancity Buzz - September 13th, 2024
Time to leverage intellectual property to drive innovation in seed and biotechnology sectors: Experts - The Times of India - May 5th, 2024
Where Does Capricor Therapeutics Inc (CAPR) Stock Fall in the Biotechnology Field After It Has Risen 24.73% This Week? - InvestorsObserver - March 10th, 2024
Where Does SpringWorks Therapeutics Inc (SWTX) Stock Fall in the Biotechnology Field After It Has Gained 12.41% This Week? - InvestorsObserver - February 18th, 2024
Should Biotechnology Stock Axsome Therapeutics Inc (AXSM) Be in Your Portfolio Wednesday? - InvestorsObserver - February 18th, 2024
Where Does Candel Therapeutics Inc (CADL) Stock Fall in the Biotechnology Field After It Has Gained 22.38% This Week? - InvestorsObserver - February 18th, 2024
What is Biotechnology? Types and Applications - Iberdrola - January 25th, 2024
Where Does Immunitybio Inc (IBRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.32% This Week? - InvestorsObserver - January 25th, 2024
Can Sana Biotechnology Inc (SANA) Stock Rise to the Top of Healthcare Sector Monday? - InvestorsObserver - January 25th, 2024
Should You Buy Sana Biotechnology Inc (SANA) Stock After it Has Fallen 15.41% in a Week? - InvestorsObserver - January 25th, 2024
Where Does Tscan Therapeutics Inc (TCRX) Stock Fall in the Biotechnology Field After It Is Lower By -9.81% This Week? - InvestorsObserver - January 25th, 2024
Should Biotechnology Stock Mink Therapeutics Inc (INKT) Be in Your Portfolio Monday? - InvestorsObserver - May 9th, 2023
Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Has Risen 22.18% This Week? - InvestorsObserver - May 9th, 2023
Should Biotechnology Stock Dermata Therapeutics Inc (DRMA) Be in Your Portfolio Thursday? - InvestorsObserver - May 9th, 2023
Should Biotechnology Stock Tempest Therapeutics Inc (TPST) Be in Your Portfolio Wednesday? - InvestorsObserver - May 9th, 2023
Biotechnology - Applications of biotechnology | Britannica - May 1st, 2023
Where Does BioLine RX Ltd - ADR (BLRX) Stock Fall in the Biotechnology Field After It Is Down -3.67% This Week? - InvestorsObserver - May 1st, 2023
Where Does Apellis Pharmaceuticals Inc (APLS) Stock Fall in the Biotechnology Field After It Is Higher By 4.17% This Week? - InvestorsObserver - May 1st, 2023
Where Does Aldeyra Therapeutics Inc (ALDX) Stock Fall in the Biotechnology Field After It Is Lower By -11.45% This Week? - InvestorsObserver - May 1st, 2023
Is Rain Oncology Inc (RAIN) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - April 7th, 2023
Does Sana Biotechnology Inc (SANA) Have What it Takes to be in Your Portfolio Tuesday? - InvestorsObserver - April 7th, 2023
Where Does Ambrx Biopharma Inc - ADR (AMAM) Stock Fall in the Biotechnology Field After It Is Lower By -15.43% This Week? - InvestorsObserver - April 7th, 2023
Where Does Protagonist Therapeutics Inc (PTGX) Stock Fall in the Biotechnology Field After It Has Risen 3.62% This Week? - InvestorsObserver - April 7th, 2023
What is Biotechnology? Definition, Types and Applications | TechTarget - March 21st, 2023
Where Does Novavax Inc (NVAX) Stock Fall in the Biotechnology Field After It Is Lower By -12.99% This Week? - InvestorsObserver - March 21st, 2023
Should Biotechnology Stock Outlook Therapeutics Inc (OTLK) Be in Your Portfolio Thursday? - InvestorsObserver - March 21st, 2023
SANA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com - March 21st, 2023
Where Does Revance Therapeutics Inc (RVNC) Stock Fall in the Biotechnology Field After It Is Lower By -2.17% This Week? - InvestorsObserver - March 5th, 2023
Is TG Therapeutics Inc common stock (TGTX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - March 5th, 2023
Where Does GT Biopharma Inc (GTBP) Stock Fall in the Biotechnology Field After It Is Down -20.73% This Week? - InvestorsObserver - March 5th, 2023
Where Does Dyne Therapeutics Inc (DYN) Stock Fall in the Biotechnology Field After It Is Lower By -2.35% This Week? - InvestorsObserver - March 5th, 2023
Is CytomX Therapeutics Inc (CTMX) Stock at the Top of the Biotechnology Industry? - InvestorsObserver - November 17th, 2022

This entry was posted on August 4, 2016 at 9:35 am and is filed under Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |

Comments are closed.

StemCell Therapy

Semi-solid state fermentation of bagasse for hydrogen …

Categories

Archives

Recommended Sites

Recent Posts